The creation of this new approach to stopping bleeding has unparalleled potential if moved forward in the medical industry, and could save countless lives in the process. As SciTechDaily first ...

Hemab Therapeutics, a late stage clinical biotechnology company developing novel prophylactic therapeutics for serious, underserved coagulation disorders, today announced that the U.S. Food and Drug ...